Home Newsfeeds Morgan Stanley Maintains Overweight on S&P Global, Lowers Price Target to $398

Morgan Stanley Maintains Overweight on S&P Global, Lowers Price Target to $398

Morgan Stanley analyst Toni Kaplan maintains S&P Global (NYSE:SPGI) with a Overweight and lowers the price target from $401 to $398.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Morgan Stanley analyst Toni Kaplan maintains S&P Global (NYSE:SPGI) with a Overweight and lowers the price target from $401 to $398.

Analyst Ratings

Demystifying Cipher Mining: Insights From 12 Analyst Reviews

By Benzinga Insights

May 8, 9:00 AM

Cipher Mining (NASDAQ:CIFR) has been analyzed by 12 analysts in the last three months, revealing a diverse range…

CIFR

Relmada Therapeutics Announces Efficacy And Safety Results From The Phase 3 Long-Term Study Of REL-1017 In Major Depressive Disorder

By Benzinga Newsdesk

September 20, 8:31 AM

Patients newly treated with REL-1017 for up to one year experienced rapid, clinically meaningful, and sustained improvements in depressive symptoms and associated functional impairmentLong-term dosing with REL-1017 was

RLMD

Battery Materials Maker Nexeon Inks Supply Agreement With Panasonic

By Shivani Kumaresan

July 25, 10:30 AM

Battery materials and manufacturing company Nexeon has entered into a supply partnership with Panasonic Energy Co., Ltd., a Panasonic Holdings Corp (OTC:PCRFY) company. Nexeon has…

PCRFY

AssetMark Financial Holdings, Inc. Established Succession Plan, Michael Kim Has Been Named The Company’s New Chief Executive Officer, Effective Immediately

By Benzinga Newsdesk

September 8, 4:01 PM

AssetMark Financial Holdings, Inc. (NYSE:AMK) today announced that, in line with the AssetMark Board of Directors' established succession plan, Michael Kim has been named the company's new Chief Executive Officer,

AMK

Morgan Stanley Maintains Overweight on S&P Global, Lowers Price Target to $398

Related Posts

Demystifying Cipher Mining: Insights From 12 Analyst Reviews

Relmada Therapeutics Announces Efficacy And Safety Results From The Phase 3 Long-Term Study Of REL-1017 In Major Depressive Disorder

Battery Materials Maker Nexeon Inks Supply Agreement With Panasonic

AssetMark Financial Holdings, Inc. Established Succession Plan, Michael Kim Has Been Named The Company’s New Chief Executive Officer, Effective Immediately